NervGen Pharma to Present Two Posters at the American Spinal Injury Association 51st Annual Scientific Meeting
NervGen Pharma Corp. , a clinical-stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, announced today that Daniel Mikol, MD, Ph.D., Chief...